For over 3 years, RealWorld EDC and leading Japanese CRO, CMIC, have been working together, localising and tailoring the RealWorld Data Solution applications, to bring benefits to pharma for studies in Japan.
CMIC Group pioneered the CRO business in Japan. Most of the new drug development in the country is supported by CMIC’s efforts.
Key Milestones in Japan
In May 2018, RealWorld EDC passed its first audit by a Japanese CRO. The following month- in June, the Company passed a Japanese pharma audit. We started our first two studies in Japan in 2018 for two of the leading Japanese pharmaceuticals companies in two therapeutic areas: Ophthalmology and Biological Medicine.